Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Understanding Rare Conditions: The Multifaceted Financial Impact

January 26, 2023

More than a third of Health Union’s Myasthenia Gravis In America 2022 survey respondents said their condition has negatively impacted their finances.

Bringing Patient Centricity to Life: Health Union’s Social Health Network

December 7, 2022

Health Union's Social Health Network builds health leaders into confident and trustworthy partners for the healthcare industry. Here's why that matters.

Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience

November 30, 2022

Two health leaders share wins, challenges and opportunities they've faced as patient and caregiver to help pharma improve the chronic condition experience.

Understanding Rare Conditions: Support & Connection

November 8, 2022

The internet has allowed people living with chronic conditions to find information, connection and support that might not have been readily available.

A Patient’s Story Amplified: Data, emotion, and the role pharma can play

October 30, 2019

This livestream webinar helps pharma understand how integrating patient-reported data creates meaningful engagement at all points in the patient journey.

Make Content Relevant for the Right People

October 29, 2019

Providing relevant content at the right time, to the right people, builds trust with our audience, something more valuable than creation for SEO.

Biologic Therapies for Crohn’s and Colitis Patients

October 8, 2019

Survey results reveal opportunities to help strengthen conversations about biologic therapies between people with Crohn’s or colitis and their doctors.

Patient Interest in Digital Inhaler for Asthma and COPD

October 2, 2019

Survey data of asthma and COPD patients show that nearly half of each surveyed population are highly interested in using a digital inhaler.

Healthcare Industry Thought Leadership

Contact